ALC:SWX
Alcon AG
CHFÂ 54.88
arrow_upward
+1.67%(+0.90) 1D
Sep 14, 3:35:12 PM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
CHFÂ 54.46
High
CHFÂ 55.20
Low
CHFÂ 54.20
Mkt. cap
27.55B
Avg. vol.
1.15M
Volume
316.58K
Dividend
0.51%
Quarterly dividend
CHFÂ 0.07
Ex-dividend date
May 5, 2026
P/E ratio
51.58
52-wk high
CHFÂ 68.34
52-wk low
CHFÂ 47.80
EPS
CHFÂ 1.06
Shares outstanding
499.70M
No. of employees
25K
Open
CHFÂ 54.46
High
CHFÂ 55.20
Low
CHFÂ 54.20
Mkt. cap
27.55B
Avg. vol.
1.15M
Volume
316.58K
Dividend
0.51%
Quarterly dividend
CHFÂ 0.07
Ex-dividend date
May 5, 2026
P/E ratio
51.58
52-wk high
CHFÂ 68.34
52-wk low
CHFÂ 47.80
EPS
CHFÂ 1.06
Shares outstanding
499.70M
No. of employees
25K
News stories
From web sources and news partners
ad-hoc-news.de
·
1 hour ago
Alcon stock gains after Q2 2026 earnings beat and outlook raise
ad-hoc-news.de
·
1 day ago
Alcon stock gains on Q2 2026 earnings beat and Berenberg Buy rating
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorMedical device
Websitealcon.com